-+ 0.00%
-+ 0.00%
-+ 0.00%

BOSTON SCIENTIFIC EXEC SAYS EXPECTS TOP-LINE PRESSURE TO PERSIST INTO 2027, MAKING REVENUE AND EPS GROWTH CHALLENGING EXCLUDING PENUMBRA DEAL

Reuters·10/28/2026 12:29:09